PEASE-1

Al Discussion on mHSPC Treatment Options -Using Doublet and Triplet Treatments

Al Discussion on mHSPC Treatment Options -Using Doublet and Triplet Treatments

Treatment options for men with metastatic hormone sensitive prostate cancer (mHSPC) have changed. Dr. Catherine Marshal from Johns Hopkins shares her insight into the current treatment landscapes, including the use of doublet and triplet therapies.